Amlodipine Besylate Tablet
Product Images NDC 43063-764

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 43063-764). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063764 Label (43063764)

43063764 Label (43063764)
This is a medication label for AmLODIPine Besylate USP with a dosage of 2.5mg, containing 30 tablets per bottle. Patients are advised to finish all medication unless otherwise instructed by a doctor. They are also warned to watch for side effects and to report such to the FDA. The pills are white, round, and are marked with 126C, the NDC code is 43063-764-30. The label also includes information about the manufacturer and an expiration date of 01/50. The label is partially in Spanish, indicating that the tablets may be taken several times a day, and the label also specifies that each tablet contains amLODIPine Besylate USP equivalent to 2.5mg of amLODIPine.*
FDA Label Image

Dc48db65 Ee80 4852 A3aa A23ec74f4416 01

FDA Label Image

Dc48db65 Ee80 4852 A3aa A23ec74f4416 02

Dc48db65 Ee80 4852 A3aa A23ec74f4416 02
This is a statistical report with information regarding an event rate. The p-value is 0.003 and the hazard ratio is 0.691 with a 95% confidence level ranging from 0.54 to 0.88. There is a graph with time (in months) and risk, and the data seems to involve the medication Amlodipine.*
FDA Label Image

Dc48db65 Ee80 4852 A3aa A23ec74f4416 03

Dc48db65 Ee80 4852 A3aa A23ec74f4416 03
This appears to be a table regarding a study comparing the effectiveness of Amlodipine versus Placebo. The table includes information about the patient population, including age, gender, and baseline blood pressure levels, as well as details about pre-existing vessel disease and stenosis. There are also categories for patients who underwent PCI-stent placement. The data is in the form of counts and percentages, and there are some confidence intervals provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.